Study on the Effect of a Cannabis-Based Herbal Formulation for Reducing Inflammation in Osteoarthritis Patients

A SINGLE-ARM, OPEN-LABEL INTERVENTIONAL STUDY TO EVALUATE THE ANTI-INFLAMMATORY EFFECT OF A CANNABIS BASED FORMULATION WSR TO OSTEOARTHRITIS. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107894

Enrollment

Registered

2026-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M199- Osteoarthritis, unspecified site

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Male or female subjects who are suffering from Osteo Arthritis. Subjects willing to give a written informed consent and agree to come for a regular follow-up visit. Subjects willing to abide by and comply with the study protocol. Subjects who have not participated in a similar investigation in the past three months. Subjects who have not taken any analgesics or NSAIDs, etc for a period of 15 days before the start of the trial and are willing to avoid them till the end of the trial.

Exclusion criteria

Exclusion criteria: Subjects who have undergone invasive treatments like surgery within 3 months before screening into the study. Subjects having any active disease that may interfere with the study. Any history of underlying uncontrolled medical illness, including diabetes mellitus, hypertension, HIV, hepatitis, severe anaemia, serious disorder of the heart and respiratory apparatus or any other serious medical illness. A known history or present condition of allergic response/hypersensitivity to any ingredients and pharmaceutical products. Subjects who had been part of any other clinical study within 3 months before screening into the study.

Design outcomes

Primary

Measure	Time frame
Evaluation of Anti-Inflammatory Effect in Osteo-Arthritis Patients treated with Cannabis based Polyherbal formulationTimepoint: Baseline, 30 Days (After Treatment) and 90 Days (After follow-up)	—

Secondary

Measure	Time frame
Evaluation of Pain Reduction.Timepoint: Baseline, Day 7, Day 15, Day 21, Day 30 (After Treatment), Day 60 & Day 90 (After Follow-up);Evaluation of Quality of LifeTimepoint: Baseline, Day 7, Day 15, Day 21, Day 30 (After Treatment), Day 60 & Day 90 (After Follow-up);Evaluation of ESR & CRPTimepoint: Baseline & Day 30.	—

Countries

India

Contacts

Public ContactDr Mahesh T S

Prasanna College of Ayurveda and Hospital

agravishankar75@gmail.com9448260242

Outcome results